| Primary |
| Drug Use For Unknown Indication |
83.8% |
| Convulsion |
11.0% |
| Epilepsy |
2.7% |
| Accidental Exposure |
0.5% |
| Complex Partial Seizures |
0.5% |
| Febrile Convulsion |
0.5% |
| Grand Mal Convulsion |
0.5% |
| Product Used For Unknown Indication |
0.5% |
|
| Poisoning |
25.8% |
| Pharmaceutical Product Complaint |
11.7% |
| Unresponsive To Stimuli |
11.7% |
| Drug Abuse |
6.7% |
| Somnolence |
5.0% |
| Completed Suicide |
4.2% |
| Death |
4.2% |
| Drug Ineffective |
4.2% |
| Pulmonary Oedema |
3.3% |
| Respiratory Depression |
3.3% |
| Underdose |
3.3% |
| Therapeutic Response Delayed |
2.5% |
| Wrong Technique In Drug Usage Process |
2.5% |
| Convulsion |
1.7% |
| Device Failure |
1.7% |
| Drug Dispensing Error |
1.7% |
| Incorrect Dose Administered |
1.7% |
| Intentional Drug Misuse |
1.7% |
| Loss Of Consciousness |
1.7% |
| Medication Error |
1.7% |
|
| Secondary |
| Convulsion |
34.6% |
| Epilepsy |
26.9% |
| Partial Seizures |
15.4% |
| Prophylaxis |
15.4% |
| Accidental Exposure |
7.7% |
|
| Tonic Clonic Movements |
30.8% |
| Pharmaceutical Product Complaint |
15.4% |
| Somnolence |
15.4% |
| Device Malfunction |
7.7% |
| Faecal Incontinence |
7.7% |
| Pulmonary Haemorrhage |
7.7% |
| Rectal Polyp |
7.7% |
| Status Epilepticus |
7.7% |
|
| Concomitant |
| Convulsion |
29.6% |
| Product Used For Unknown Indication |
15.3% |
| Epilepsy |
14.8% |
| Drug Use For Unknown Indication |
8.8% |
| Tuberous Sclerosis |
4.3% |
| Asthma |
2.5% |
| Pain |
2.5% |
| Constipation |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Multiple Sclerosis |
2.3% |
| Lennox-gastaut Syndrome |
1.8% |
| Vitamin Supplementation |
1.8% |
| Infantile Spasms |
1.6% |
| Prophylaxis |
1.6% |
| Headache |
1.4% |
| Muscle Spasticity |
1.4% |
| Pyrexia |
1.4% |
| Agitation |
1.3% |
| Anxiety |
1.3% |
| Partial Seizures |
1.3% |
|
| Convulsion |
19.5% |
| Vomiting |
13.8% |
| Pneumonia |
5.7% |
| Product Substitution Issue |
5.7% |
| Weight Increased |
5.7% |
| Sleep Disorder |
4.6% |
| Status Epilepticus |
4.6% |
| Tremor |
4.6% |
| Atrioventricular Block |
3.4% |
| Blood Sodium Decreased |
3.4% |
| Death |
3.4% |
| Drug Ineffective |
3.4% |
| Pharmaceutical Product Complaint |
3.4% |
| Upper Respiratory Tract Infection |
3.4% |
| Urinary Tract Infection |
3.4% |
| Decreased Appetite |
2.3% |
| Lethargy |
2.3% |
| Medication Residue |
2.3% |
| Mouth Ulceration |
2.3% |
| Nasopharyngitis |
2.3% |
|
